Copyright
©The Author(s) 2016.
World J Hepatol. Jan 18, 2016; 8(2): 92-106
Published online Jan 18, 2016. doi: 10.4254/wjh.v8.i2.92
Published online Jan 18, 2016. doi: 10.4254/wjh.v8.i2.92
Figure 3 ION-2 sub-analysis of cirrhosis vs without cirrhosis.
Error bars represent 95%CIs. LDV: Ledipasvir; RBV: Ribavirin; SOF: Sofosbuvir; SVR12: Sustained virologic response at 12 wk post-treatment.
- Citation: Bertino G, Ardiri A, Proiti M, Rigano G, Frazzetto E, Demma S, Ruggeri MI, Scuderi L, Malaguarnera G, Bertino N, Rapisarda V, Di Carlo I, Toro A, Salomone F, Malaguarnera M, Bertino E, Malaguarnera M. Chronic hepatitis C: This and the new era of treatment. World J Hepatol 2016; 8(2): 92-106
- URL: https://www.wjgnet.com/1948-5182/full/v8/i2/92.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i2.92